MT1002

· Shaanxi Micot Pharmaceutical Technology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MT1002, covering 2024-08-01 to 2024-08-01. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study of MT1002 in Subjects With Acute Coronary Syndrome Undergoing PCI [Phase 2]